Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 18 Breast Neoplasms 14 Pain 5 Lung Neoplasms 5 Neoplasms 3 Agnosia 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Goiter 2 Colorectal Neoplasms 2 Chronic Pain 2 Breast Cancer Female 2 Abdominal Cancer 2 post laminectomy syndrome 1 Uterine Cervical Dysplasia 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Respiration Disorders 1 Reperfusion Injury 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peritoneal Cancer 1 Neuroma 1 Neuralgia 1 Mucositis 1 Liver Neoplasms 1 Leiomyoma 1 Laryngeal Neoplasms 1

Interventions

soybean oil, phospholipid emulsion 1 blinatumomab 1 Stents 1 Radiotherapy, Conformal 1 Passive Cutaneous Anaphylaxis 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 ClinOleic 1 Bupivacaine 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bites and Stings × Bupivacaine × Clear all

NCT03165383 2017-05-24

TAP

Rajiv Gandhi Cancer Institute & Research Center, India

Phase NA Completed

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡